BMC Complementary Medicine and Therapies

Table 8 Cell viability (%) of the CPE against HDFa in comparison with PBE and AA

From: Phenolic composition, antioxidant, anti-wrinkles and tyrosinase inhibitory activities of cocoa pod extract

Sample	Concentration, μg/ml									IC ₉₀
	3.9	7.8	15.6	31.3	62.5	125	250	500	1000
AA	14.35 ± 3.04^bα	18.70 ± 1.84^{c α}	22.17 ± 0.61^{c β}	36.96 ± 4.30^aγ	40.87 ± 3.69^cδ	108.26 ± 24.90^aε	590.43 ± 19.68^a€	1407.39 ± 46.12^a£	651.30 ± 133.04^a€	57.10
PBE	17.95 ± 1.21^bα	24.79 ± 2.42^bβ	29.49 ± 1.81^bγ	42.31 ± 5.44^aδ	69.23 ± 1.21^aε	118.35 ± 1.81^a€	202.14 ± 42.91^b£	335.47 ± 17.53^bζ	285.47 ± 49.56^b£ζ	101.21
CPE	368.47 ± 46.15^aγ	62.32 ± 4.49^aβ	40.80 ± 7.41^aα	39.92 ± 2.74^aα	55.62 ± 8.32^bβ	58.47 ± 6.26^bβ	61.75 ± 11.20^cβ	76.83 ± 12.25^cβ	62.82 ± 10.11^cβ	7.42

^{a b c d}Different alphabet in column means significantly different within concentration.
^{α β γ δ ε € £}different symbol means significantly different within concentration for each sample in row.

Back to article page

ISSN: 2662-7671

Contact us

Submission enquiries: bmccomplementarymedicineandtherapies@biomedcentral.com
General enquiries: ORSupport@springernature.com